[go: up one dir, main page]

MX2009004980A - Composiciones topicas que comprenden polihidroxi acidos y/o lactonas para efectos cutaneos mejorados de farmacos terapeuticos oxidantes. - Google Patents

Composiciones topicas que comprenden polihidroxi acidos y/o lactonas para efectos cutaneos mejorados de farmacos terapeuticos oxidantes.

Info

Publication number
MX2009004980A
MX2009004980A MX2009004980A MX2009004980A MX2009004980A MX 2009004980 A MX2009004980 A MX 2009004980A MX 2009004980 A MX2009004980 A MX 2009004980A MX 2009004980 A MX2009004980 A MX 2009004980A MX 2009004980 A MX2009004980 A MX 2009004980A
Authority
MX
Mexico
Prior art keywords
topical compositions
lactones
polyhydroxy
therapeutic drugs
polyhydroxy acids
Prior art date
Application number
MX2009004980A
Other languages
English (en)
Inventor
Barbara A Green
David J Milora
Original Assignee
Neostrata Company Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neostrata Company Inc filed Critical Neostrata Company Inc
Publication of MX2009004980A publication Critical patent/MX2009004980A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/38—Percompounds, e.g. peracids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)

Abstract

Las modalidades se relacionan generalmente a composiciones tópicas útiles para tratar o prevenir una variedad de condiciones cosméticas y desórdenes dermatológicos, donde la composición comprende un fármaco farmacéutico oxidante y un polihidroxi ácido o polihidroxi lactona antioxidante. El polihidroxi ácido o polihidroxi lactona mejora los efectos cutáneos del fármaco. Las modalidades además se relacionan al tratamiento de una variedad de condiciones cosméticas y desordenes dermatológicos que comprende la administración a un sujeto de una cantidad efectiva de la composición y a métodos para hacer las composiciones.
MX2009004980A 2006-11-10 2007-11-13 Composiciones topicas que comprenden polihidroxi acidos y/o lactonas para efectos cutaneos mejorados de farmacos terapeuticos oxidantes. MX2009004980A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86524406P 2006-11-10 2006-11-10
PCT/US2007/023757 WO2008060515A2 (en) 2006-11-10 2007-11-13 Topical compositions comprising polyhydroxy acids and/or lactones for improved cutaneous effects of oxidative therapeutic drugs

Publications (1)

Publication Number Publication Date
MX2009004980A true MX2009004980A (es) 2009-09-04

Family

ID=39313051

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009004980A MX2009004980A (es) 2006-11-10 2007-11-13 Composiciones topicas que comprenden polihidroxi acidos y/o lactonas para efectos cutaneos mejorados de farmacos terapeuticos oxidantes.

Country Status (4)

Country Link
US (1) US20080113037A1 (es)
CA (1) CA2669539A1 (es)
MX (1) MX2009004980A (es)
WO (1) WO2008060515A2 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2338465A1 (en) 2005-11-09 2011-06-29 Klox Technologies Inc. Teeth whitening compositions and methods
US20100266989A1 (en) 2006-11-09 2010-10-21 Klox Technologies Inc. Teeth whitening compositions and methods
LT2352488T (lt) 2008-11-07 2017-05-25 Klox Technologies Inc. Oksidacinė fotoaktyvuojama odos atjauninimo kompozicija, apimanti hialurono rūgštį, gliukozaminą arba alantoiną
EP2405886B8 (en) * 2009-03-11 2017-11-01 ISP Investments LLC Topical personal care and pharmaceutical compositions and uses thereof
SMT201700575T1 (it) 2009-07-17 2018-01-11 Klox Tech Inc Composizione orale antibatterica
US8722026B2 (en) 2010-01-06 2014-05-13 Elc Management, Llc Skin lightening compositions
US8992897B2 (en) 2010-01-06 2015-03-31 Elc Management Llc Skin lightening compositions
WO2013115759A1 (en) * 2012-02-01 2013-08-08 Horvat Branimir L Topical medications for controlling epidermal symptoms
US20130281913A1 (en) 2012-04-20 2013-10-24 Klox Technologies Inc. Biophotonic compositions and methods for providing biophotonic treatment
US11116841B2 (en) 2012-04-20 2021-09-14 Klox Technologies Inc. Biophotonic compositions, kits and methods
CA2884349C (en) 2012-09-14 2019-03-26 Valeant Pharmaceuticals International, Inc. Compositions and methods for teeth whitening
US20140276354A1 (en) 2013-03-14 2014-09-18 Klox Technologies Inc. Biophotonic materials and uses thereof
WO2015000058A1 (en) 2013-07-03 2015-01-08 Klox Technologies Inc. Biophotonic compositions comprising a chromophore and a gelling agent for treating wounds
AU2015240385B2 (en) 2014-04-01 2019-02-28 Klox Technologies Inc. Tissue filler compositions and methods of use
JP2018500468A (ja) 2014-10-31 2018-01-11 クロックス テクノロジーズ インコーポレイテッドＫｌｏｘ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｉｎｃ． 光活性性の繊維および織物媒体
KR101899413B1 (ko) * 2018-05-03 2018-09-18 주식회사 케어사이드 피부 감염의 예방 또는 치료용 조성물
GB2596286B (en) * 2020-06-20 2023-01-25 Francis Davis Adrian Adherence to topical therapy
CN118071531A (zh) * 2024-02-01 2024-05-24 重庆地质矿产研究院 一种露天矿山生态系统恢复力评价方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1002264A (en) * 1962-10-15 1965-08-25 Chugai Pharmaceutical Co Ltd Improvements in or relating to therapeutic compositions comprising glucuronic acid
JPS60161916A (ja) * 1984-02-01 1985-08-23 Shiseido Co Ltd 皮膚外用剤
US4678663A (en) * 1984-02-06 1987-07-07 Nuetrogena Corporation Hydroquinone composition having enhanced bio-availability and percutaneous adsorption
US5648389A (en) * 1995-10-27 1997-07-15 Medicis Pharmaceutical, Inc. Compositions for the treatment of dermatological disorders and methods for their use
US6472432B1 (en) * 1997-11-17 2002-10-29 Nicholas V. Perricone Treatment of rosacea using lipoic acid
US6036963A (en) * 1998-02-26 2000-03-14 Chesebrough-Ponds's Usa Co., Division Of Conopco, Inc. Gluconolactones and glucarolactones as anti-irritants in cosmetic compositions
SE9801647D0 (sv) * 1998-05-12 1998-05-12 Interhealth Ab Therapeutic composition
JP3549197B2 (ja) * 2001-08-10 2004-08-04 日清ファルマ株式会社 ユビキノン含有製剤
US20040220259A1 (en) * 2003-04-04 2004-11-04 Yu Ruey J. Topical treatment of dermatological disorders associated with reactive or dilated blood vessels
WO2005000224A2 (en) * 2003-06-04 2005-01-06 Ebersytes, Llc Novel dermatological composition

Also Published As

Publication number Publication date
WO2008060515A3 (en) 2008-08-28
US20080113037A1 (en) 2008-05-15
WO2008060515A2 (en) 2008-05-22
CA2669539A1 (en) 2008-05-22

Similar Documents

Publication Publication Date Title
MX2009004980A (es) Composiciones topicas que comprenden polihidroxi acidos y/o lactonas para efectos cutaneos mejorados de farmacos terapeuticos oxidantes.
Choubey et al. Medicinal importance of gallic acid and its ester derivatives: a patent review
WO2008079404A3 (en) Pharmaceutical compositions for treatment of parkinson's disease and related disorders
NZ591810A (en) Pharmaceutical compositions and related methods of delivery the composition comprises a medium chain fatty acid
MX249762B (es) Acidos aldonicos de oligosacarido y su uso topico.
NZ807894A (en) Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
MX344476B (es) Metodos de tratar trastornos pulmonares con formulaciones de amikacina liposomal.
KR101729096B1 (ko) 통증, 가려움증 및 염증을 치료하기 위한 국소 투여된 스트론튬-함유 복합체
SG10201400685SA (en) Use Of Eicosapentaenoic Acid Ethyl Ester For Treating Hypertriglyceridemia
BR0315580A (pt) Derivados de metileno uréia
JP7103752B2 (ja) 疼痛、掻痒症および炎症のためのストロンチウムをベースとする組成物および製剤
WO2009022338A3 (en) Erythropoietin and fibronectin compositions for therapeutic and cosmetic applications
WO2007138466A3 (en) Pharmaceutical compositions comprising meloxicam and tramadol combination
WO2007098142A3 (en) Oxazole ketones as modulators of fatty acid amide hydrolase
NZ594184A (en) Skin treatment
WO2004100893A3 (en) Methods for treatment of inflammatory diseases using ct-3 or analogs thereof
US20250099498A1 (en) Strontium based compositions and formulations for pain, pruritus, and inflammation
EA201170108A1 (ru) Сосательная композиция для лечения воспалительных заболеваний полости рта и глотки
Kim et al. A literature review of bioactive substances for the treatment of periodontitis: In vitro, in vivo and clinical studies
WO2008114376A1 (ja) メラニン生成抑制組成物
WO2008063563B1 (en) Methods of treating keratin hyperproliferation disorders using mtor inhibitors
EA201101246A1 (ru) Инъекционная лекарственная форма для лечения острого ишемического инсульта и черепно-мозговой травмы, способ ее изготовления и применение
UA94975C2 (ru) Композиция и ее применение для лечения гипергликемии и связанных с ней болезней
AU2015268649B2 (en) A composition and method of applying same & a composition that assists healing burns and wounds with antibacterial and anti-fungal actions
WO2009045054A3 (en) A composition for treatment of conjunctivitis comprising chlorogenic acid and derivatives thereof